[{"data":1,"prerenderedAt":378},["ShallowReactive",2],{"story-35797-tw":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":55,"questions":56,"relatedArticles":72,"body_color":376,"card_color":377},"35797",null,"J&J's $50B Oncology Gambit: Pharma Market Disruption Signals","- Strategic Shift Reveals $25B Cancer Drug Opportunity for Healthcare Sellers",[],[10,11,12,13,14,15,16,17,18,19,20,11,21,22,23,10,24,25,26,27,19,28,17,29,30,31,32,11,33,34,35,36,37,38,39,40,41,42,43,11,44,45,19,46,21,47,23,48,41,49,50,51,19,45,52,53,54,17,17],"https://insights.citeline.com/resizer/v2/XMARSQGE7FOL5PGXKUA6VUAMWA.jpg?smart=true&auth=837818c3c4d45601427ba3c2a3b95bd823106561848e49fde3a4ee742a8280c6&width=700&height=394","https://images.wsj.net/im-79283896?width=700&height=467","https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1IIJBm.img?w=640&h=351&m=4&q=74","https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg","https://i-invdn-com.investing.com/trkd-images/LYNXMPEM0K0OH_L.jpg","https://cdn.benzinga.com/files/images/story/2026/01/21/Johnson--Johnson.jpeg?width=1200&height=800&fit=crop","https://s.yimg.com/ny/api/res/1.2/V6rQVIHjYzFoXipN0C1iRg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE4MDA7aD0xMjAw/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462","https://images.mktw.net/im-92558013?width=1260&height=835","https://www.investors.com/wp-content/uploads/2026/01/stock-johnson-building-adobe.jpg","https://images.barrons.com/im-473510?width=700&height=466","https://cdn.ttweb.net/News/images/374872.jpg?preset=w800_q70","https://assets.tegnaone.com/assets/AssociatedPress/images/d2c97eb8-b133-4fc7-8b35-0a9f32bd1a73/20260121T113005/d2c97eb8-b133-4fc7-8b35-0a9f32bd1a73.png","https://endpoints.news/wp-content/uploads/2026/01/GettyImages-2243715032-scaled.jpg","https://imgproxy.divecdn.com/hE2QhU4MyPx5bYlvf2LE2lnSehHWX6AI8ScoCn_Lxj0/g:nowe:208:253/c:1738:982/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS85MzMxNjUxLWZhY3Rvcnktc2hvdC5qcGc=.webp","https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1423187486-750x406.jpg","https://static.biospace.com/dims4/default/5f723f0/2147483647/strip/true/crop/2000x1126+0+104/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2F86%2F0d%2F65b5b95e4f429abd29d4e84468ef%2Fjnj-image-2.jpg","https://www.pymnts.com/wp-content/uploads/2026/01/Johnson-Johnson-1.jpg?w=457","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/JNJ_3.jpg?VersionId=hRIODVh7lrvfP0gVjXzMM2YaWLvWikAV","https://s.yimg.com/ny/api/res/1.2/QrIG9zF4mQn_dJdaHbvBlg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/the_wall_street_journal_hosted_996/db8e02f77993cf40ac929ab3899b472a","https://cloudfront-us-east-1.images.arcpublishing.com/morningstar/Y5GCIVFOLREPXPM42MPMPEEMDI.jpg","https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154390289/image_2154390289.jpg?io=getty-c-w1280","https://s.yimg.com/os/en/us.finance.gurufocus/f0270a56e393ba2e4d03ca6907bb8c96","https://s.yimg.com/os/en/Benzinga/5d8b94cde5c558f7a4444a84ebfd4296","https://s.yimg.com/ny/api/res/1.2/y2fSr4PEukR9wIA.0.zO5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNw--/https://media.zenfs.com/en/the_edge_961/f5c5b52bddb33a212fcd05fcc01e73c3","https://www.reuters.com/resizer/v2/N7PQZTSITNMI3HPOHOF36HVYXE.jpg?auth=9cef26cb38c0fe2db244f459fcafacee0d125211d4d575b23bd8af6188552988&width=1920&quality=80","https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625","https://ts2.tech/wp-content/uploads/2026/01/why-johnson-johnson-stock-is-slipping-today-after-jnjs-2026-forecast-featured.jpg","https://cardiovascularbusiness.com/sites/default/files/styles/top_stories/public/2025-11/istock-467671852.jpg.webp?itok=BwzPnieU","https://www.theglobeandmail.com/resizer/v2/I3PC376VZ5PGNJGDQOVU3BFUZQ.jpg?auth=f9108fdf644b8aacb36188bef94880ea3ba27f03609c3bb2f57174a9111646e8&width=1200&height=900&quality=80&smart=true","https://d5bp8bijhhba2.cloudfront.net/image/cover_image/df65758ae5cee9af48ed2fcab447995c524ef7f9d6e9648669c96adb23e84063.jpeg","https://static.gurufocus.com/logos/0C00000BO5.png?14","https://marketminute.ghost.io/content/images/size/w1200/2026/01/e6942660-5885-4a78-b775-33c753c2fe60.png","https://d1-invdn-com.investing.com/content/pic930fe58b1605f076380d9039a24b8755.png","https://www.marketbeat.com/logos/johnson--johnson-logo-1200x675.png?v=20221020135923","https://www.thedailyupside.com/wp-content/uploads/2026/01/iStock-1916635270-scaled-e1769032031633.jpg","https://newsfile.futunn.com/news-thumbnail/20240703/public/17199789871293693385095-news-thumbnail/20240703/public/17199789871299663524151.jpg","https://cdn.news.alphastreet.com/wp-content/uploads/2019/04/Earnings-Coverage-1.jpg","http://www.baystreet.ca/images/articlegroups/original/17/techinsider1.jpg","https://s.yimg.com/os/en/zacks.com/74bab520128f201c7e6cc3f67385e761","https://medicalbuyer.co.in/wp-content/uploads/2026/01/JJ-sales-up-9.1-to-USD-24.6B-in-Q4-2025.jpg","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/im6w1d5P87oQ/v0/-1x-1.webp","https://image.cnbcfm.com/api/v1/image/108210812-1760124319878-gettyimages-2239744238-JJ_PROTAGONIST_THERAPEUTICS.jpeg?v=1767924701&w=1600&h=900","https://blog.tipranks.com/wp-content/uploads/2026/01/shutterstock_1856744740-750x406.jpg","https://www.devdiscourse.com/remote.axd?https://devdiscourse.blob.core.windows.net/aiimagegallery/28_05_2024_13_01_51_4110067.png?width=1280","https://c.firstwordpharma.com/firstwordgroup/assets/adobe/images/money_grows_on_trees.jpeg","**Johnson & Johnson is executing a transformative oncology strategy that creates massive market opportunities across healthcare and e-commerce ecosystems.** The company's aggressive pivot toward cancer treatments represents a $50 billion market repositioning by 2030, with profound implications for digital sellers, medical suppliers, and healthcare technology platforms.\n\n**Key Strategic Signals for Sellers:**\n- Oncology represents J&J's primary growth vector, with 28 product platforms generating $1B+ revenue\n- Multiple myeloma drugs (Darzalex, Carvykti) are driving significant market expansion\n- The company projects double-digit growth through strategic focus on six core therapeutic areas\n\n**Market Dynamics and Seller Opportunities:**\nPharmaceutical e-commerce and medical supply sellers should recognize this strategic shift as a critical inflection point. The 9% revenue growth and $25.4 billion cancer drug sales in 2025 indicate massive untapped market potential. Emerging opportunities include:\n\n1. Specialized medical equipment and support products for oncology treatments\n2. Digital health platforms supporting cancer patient care\n3. Complementary wellness and supportive care product lines\n4. Telemedicine and remote patient monitoring technologies\n\n**Competitive Landscape Insights:**\nRival companies like Boston Scientific are also aggressively expanding, with electrophysiology unit projected to grow 76.5% to $3.36 billion. This signals a broader transformation in medical technology markets that savvy sellers can leverage through targeted product development and strategic positioning.",[57,60,63,66,69],{"title":58,"answer":59,"author":5,"avatar":5,"time":5},"How is J&J transforming its oncology strategy by 2030?","J&J aims to generate $50 billion in oncology sales by 2030, focusing on multiple myeloma drugs like Darzalex and Carvykti. The strategy involves spinning off non-core businesses and concentrating on six key therapeutic areas, with oncology as the primary growth driver.",{"title":61,"answer":62,"author":5,"avatar":5,"time":5},"What market opportunities emerge from J&J's oncology expansion?","Sellers can explore opportunities in specialized medical equipment, digital health platforms, cancer patient support products, telemedicine technologies, and complementary wellness lines. The $25.4 billion cancer drug market in 2025 indicates significant potential for innovative healthcare solutions.",{"title":64,"answer":65,"author":5,"avatar":5,"time":5},"How competitive is the oncology market currently?","The market is highly dynamic, with J&J facing competition from companies like Boston Scientific. Boston Scientific's electrophysiology unit is projected to grow 76.5% to $3.36 billion, demonstrating intense innovation and market disruption in medical technologies.",{"title":67,"answer":68,"author":5,"avatar":5,"time":5},"What financial performance signals J&J's market potential?","J&J reported 9% revenue growth in Q4 2025, reaching $24.6 billion. The company has 28 product platforms generating over $1 billion each and anticipates double-digit growth. Its stock has gained 47% over the past year, outperforming the S&P 500's 12% advancement.",{"title":70,"answer":71,"author":5,"avatar":5,"time":5},"What strategic moves is J&J making beyond oncology?","J&J is narrowing its focus to six core areas: oncology, immunology, and neuroscience. The company plans to spin off its orthopedic device business by mid-2027, demonstrating a clear strategy of concentrating resources on high-growth, high-margin therapeutic segments.",[73,78,82,86,90,94,98,102,106,110,114,118,122,125,129,133,137,141,145,149,153,157,161,164,168,172,176,180,184,188,191,195,199,203,207,211,215,219,222,226,230,234,238,242,246,250,254,258,261,265,269,273,277,280,284,287,290,293,297,300,304,309,313,317,321,325,329,333,337,340,344,348,352,355,359,363,366,370,373],{"id":74,"title":75,"source":76,"logo":40,"time":77},274460,"Johnson & Johnson Sees 2026 Profit, Sales Beating Wall Street Fo","https://www.gurufocus.com/news/8538659/johnson-johnson-sees-2026-profit-sales-beating-wall-street-forecasts","4天前",{"id":79,"title":80,"source":81,"logo":11,"time":77},274451,"J&J’s Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales - WSJ","https://www.wsj.com/business/earnings/johnson-johnson-jnj-q4-earnings-report-2025-f2a1b48f?gaa_at=eafs&gaa_n=AWEtsqeJNHZ8skIvkRvjsRwGL4xSm4vAoq3rH9y_rTfMWDnPw6HzZPtbGDnf&gaa_ts=69713519&gaa_sig=z-_wyPFl6sz3c4Iv-N6AAyIz0t6aIhUYvsLHpwjTYZOIZGydsgYs8xS-xPIXiIZwnAbzMVs94NJ3TTz6se8q2Q%3D%3D",{"id":83,"title":84,"source":85,"logo":5,"time":77},274450,"J&J Sees 2026 Profit Above Wall Street Estimates Despite Tariffs Hit, Trump Pricing Deal","https://www.usnews.com/news/top-news/articles/2026-01-21/johnson-johnson-forecasts-2026-profit-above-wall-street-estimates",{"id":87,"title":88,"source":89,"logo":32,"time":77},274453,"How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q4 Earnings","https://finance.yahoo.com/news/earn-500-month-johnson-johnson-104609986.html",{"id":91,"title":92,"source":93,"logo":28,"time":77},274452,"J&J’s Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales","https://finance.yahoo.com/news/j-j-sales-profit-rise-112000910.html",{"id":95,"title":96,"source":97,"logo":42,"time":77},274455,"JNJ Earnings Preview: Solid Q4 Expected With Revenue Growth Above 5% in Sight","https://www.investing.com/analysis/jnj-earnings-preview-solid-q4-expected-with-revenue-growth-above-5-in-sight-200673576",{"id":99,"title":100,"source":101,"logo":35,"time":77},274454,"Assessing Johnson & Johnson (JNJ) Valuation After Recent Share Price Gains","https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/assessing-johnson-johnson-jnj-valuation-after-recent-share-p",{"id":103,"title":104,"source":105,"logo":39,"time":77},274457,"Johnson & Johnson (JNJ) Reports Q4 2025 Revenue of $24.6 Billion, Pharma Business Exceeds $60 Billion for First Time","https://intellectia.ai/news/stock/johnson-johnson-jnj-reports-q4-2025-revenue-of-246-billion-pharma-business-exceeds-60-billion-for-first-time",{"id":107,"title":108,"source":109,"logo":5,"time":77},274456,"J&J Foresees Unprecedented $100B Year In Sales 01/22/2026","https://www.mediapost.com/publications/article/412208/jj-foresees-unprecedented-100b-year-in-sales.html",{"id":111,"title":112,"source":113,"logo":41,"time":77},274459,"J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape","https://markets.financialcontent.com/stocks/article/marketminute-2026-1-21-j-and-j-forecasts-100-billion-milestone-for-2026-as-trump-drug-pricing-deals-reshape-the-pharma-landscape",{"id":115,"title":116,"source":117,"logo":5,"time":77},274458,"Johnson & Johnson Expected to Report $2.46 EPS on $24.16 Billion Revenue","https://intellectia.ai/news/stock/johnson-johnson-expected-to-report-246-eps-on-2416-billion-revenue",{"id":119,"title":120,"source":121,"logo":19,"time":77},275580,"Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls.","https://www.barrons.com/articles/johnson-johnson-earnings-preview-what-to-expect-7b2c508e?gaa_at=eafs&gaa_n=AWEtsqc03zMzmtoLuBOXKBWoFnsi3VF7y8Y3eJExLmiS4LCGTOOUZbCigYOJ&gaa_ts=69716d4c&gaa_sig=clmq6b_GmwkRyT4cCf8CpAi7iyCNQ-oTmDTRxeYh8z4o6w97ZjuRHhD7cMgxeP0kVnUpr66tN4P-E9IWY-pgSw%3D%3D",{"id":123,"title":112,"source":124,"logo":41,"time":77},275574,"https://markets.financialcontent.com/wral/article/marketminute-2026-1-21-j-and-j-forecasts-100-billion-milestone-for-2026-as-trump-drug-pricing-deals-reshape-the-pharma-landscape",{"id":126,"title":127,"source":128,"logo":18,"time":77},274560,"How Two Rivals Undercut J&J's Beat And Big Guidance","https://www.investors.com/news/technology/johnson-and-johnson-stock-jnj-earnings-q4-2025/",{"id":130,"title":131,"source":132,"logo":5,"time":77},275575,"Johnson & Johnson Sees 2026 Profit, Sales Beating Wall Street Forecasts","https://finance.yahoo.com/news/johnson-johnson-sees-2026-profit-185428876.html",{"id":134,"title":135,"source":136,"logo":38,"time":77},274442,"Johnson & Johnson forecasts 2026 profit above estimates despite Trump drug-pricing hit","https://www.theglobeandmail.com/business/article-johnson-johnson-forecasts-2026-profit-above-estimates-despite-trump/",{"id":138,"title":139,"source":140,"logo":5,"time":77},275572,"Johnson & Johnson (JNJ) Surpasses Q4 Revenue Expectations","https://www.gurufocus.com/news/8536425/johnson-johnson-jnj-surpasses-q4-revenue-expectations?mobile=true",{"id":142,"title":143,"source":144,"logo":5,"time":77},275573,"Johnson & Johnson (JNJ) Reports Strong Growth and Strategic Inve","https://www.gurufocus.com/news/8540792/johnson-johnson-jnj-reports-strong-growth-and-strategic-investments-in-2025",{"id":146,"title":147,"source":148,"logo":21,"time":77},274444,"Johnson & Johnson: Q4 Earnings Snapshot","https://www.kens5.com/article/syndication/associatedpress/johnson--johnson-q4-earnings-snapshot/616-d0e6f8bb-bc0d-4701-9fb9-2015b62e561a",{"id":150,"title":151,"source":152,"logo":46,"time":77},275578,"Johnson & Johnson shares slip as healthcare firm posts solid quarterly results","https://news.alphastreet.com/johnson-johnson-shares-slip-as-healthcare-firm-posts-solid-quarterly-results/",{"id":154,"title":155,"source":156,"logo":52,"time":77},274443,"JNJ Earnings: Johnson & Johnson Stock Falls Despite Q4 Revenue Beat","https://www.tipranks.com/news/jnj-earnings-johnson-johnson-stock-falls-despite-strong-q4-results",{"id":158,"title":159,"source":160,"logo":36,"time":77},275579,"Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast","https://ts2.tech/en/why-johnson-johnson-stock-is-slipping-today-after-jnjs-2026-forecast/",{"id":162,"title":147,"source":163,"logo":21,"time":77},274446,"https://www.kare11.com/article/syndication/associatedpress/johnson--johnson-q4-earnings-snapshot/616-d0e6f8bb-bc0d-4701-9fb9-2015b62e561a",{"id":165,"title":166,"source":167,"logo":5,"time":77},275576,"Dow Jones Top Company Headlines at 1 PM ET: J&J's Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales | Nvidia ...","https://news.futunn.com/en/post/67715195/dow-jones-top-company-headlines-at-1-pm-et-j",{"id":169,"title":170,"source":171,"logo":5,"time":77},274445,"Johnson & Johnson (JNJ) Anticipates Higher Revenue in Fiscal Yea","https://www.gurufocus.com/news/8535730/johnson-johnson-jnj-anticipates-higher-revenue-in-fiscal-year-2026",{"id":173,"title":174,"source":175,"logo":5,"time":77},275577,"Cancer drugs fuel J&J's sales growth and upbeat forecast","https://firstwordpharma.com/story/7073177",{"id":177,"title":178,"source":179,"logo":30,"time":77},274448,"J&J stock drops after Q4 2025 results (JNJ:NYSE)","https://seekingalpha.com/news/4540846-jj-stock-drops-q4-2025-results",{"id":181,"title":182,"source":183,"logo":51,"time":77},274447,"Johnson & Johnson forecasts 2026 profit above Wall Street estimates","https://www.cnbc.com/2026/01/21/johnson-johnson-jnj-q4-earnings.html",{"id":185,"title":186,"source":187,"logo":17,"time":77},275778,"J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.","https://www.marketwatch.com/story/j-j-expects-to-hit-100-billion-in-revenue-next-year-after-new-strategy-pays-off-e630fb43?gaa_at=eafs&gaa_n=AWEtsqdVMBtRatWE1irVKibMdEvUw49fx4jgvRe3L3P2GCb4UlA4DXYZJVP7&gaa_ts=69716d4c&gaa_sig=_1bV59hnAyA-uW20ANANw-7NCDSy30kNvIZwulnB3yKkeQ0mdma3f1hLwA7RmeA3A-mYZpmQlrHmacB6bn18YQ%3D%3D",{"id":189,"title":186,"source":190,"logo":17,"time":77},277638,"https://www.marketwatch.com/story/j-j-expects-to-hit-100-billion-in-revenue-next-year-after-new-strategy-pays-off-e630fb43?gaa_at=eafs&gaa_n=AWEtsqfwnayVKkk-SbxbZ3Zrdm3lRrXJ4zK1mYruboIpGVqiF5itOhIGz9zR&gaa_ts=6971ddc7&gaa_sig=zSswr8rqid5J1kem5M3eDZGmMb2T00QaTDsDDw88JarRP4OT9QRnZbS3Q-3xBcprbOm1RIvOk_XrN30a7C0P9g%3D%3D",{"id":192,"title":193,"source":194,"logo":20,"time":77},274449,"J&J's Q4 sales up by 9.1% to $24.6B","https://breakingthenews.net/Article/JandJ's-Q4-sales-up-by-9.1-to-dollar24.6B/65517060",{"id":196,"title":197,"source":198,"logo":31,"time":77},275570,"Johnson & Johnson (JNJ) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...","https://finance.yahoo.com/news/johnson-johnson-jnj-q4-2025-210241219.html",{"id":200,"title":201,"source":202,"logo":37,"time":77},275571,"Johnson & Johnson CEO celebrates success of company’s cardiovascular business during Q4 earnings call","https://cardiovascularbusiness.com/topics/healthcare-management/healthcare-economics/johnson-johnson-ceo-celebrates-success-companys-cardiovascular-business-during-q4-earnings-call",{"id":204,"title":205,"source":206,"logo":48,"time":77},274473,"J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales","https://finance.yahoo.com/news/j-j-stock-down-despite-152800664.html",{"id":208,"title":209,"source":210,"logo":26,"time":77},275563,"Johnson & Johnson Says Product Launches, Regulatory Approvals Drive Growth","https://www.pymnts.com/healthcare/2026/johnson-johnson-says-product-launches-regulatory-approvals-drive-growth/",{"id":212,"title":213,"source":214,"logo":45,"time":77},276410,"Dow Jones Top Company Headlines at 3 PM ET: J&J's Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales | Nvidia ...","https://news.futunn.com/en/post/67717759/dow-jones-top-company-headlines-at-3-pm-et-j",{"id":216,"title":217,"source":218,"logo":5,"time":77},274472,"J&J expects to elevate free cash flow generation to about $21 billion in 2026 - conf call","https://www.marketscreener.com/news/j-j-expects-to-elevate-free-cash-flow-generation-to-about-21-billion-in-2026-conf-call-ce7e58d2d88af722",{"id":220,"title":80,"source":221,"logo":11,"time":77},275564,"https://www.wsj.com/business/earnings/johnson-johnson-jnj-q4-earnings-report-2025-f2a1b48f?gaa_at=eafs&gaa_n=AWEtsqeTmRM1P4st5Pgbni8zMXrCHbo_M8xpTOK8V3_ppMddFltr16m8H8yP&gaa_ts=69716d4c&gaa_sig=jzyA6hBIM6zD28UYjnlgm51C23AiFUwXVPpXDhp1_RC3bQm1gdkzqRLITglFi9mFBy4HFRTK3kXKSeIa6ygKZg%3D%3D",{"id":223,"title":224,"source":225,"logo":33,"time":77},276411,"Johnson & Johnson sees strong 2026 growth despite deal to cut prices","https://sg.finance.yahoo.com/news/johnson-johnson-sees-strong-2026-073814204.html",{"id":227,"title":228,"source":229,"logo":34,"time":77},274475,"J&J sees 2026 profit above Wall Street estimates despite tariffs hit, Trump pricing deal","https://www.reuters.com/legal/litigation/johnson-johnson-forecasts-2026-profit-above-wall-street-estimates-2026-01-21/",{"id":231,"title":232,"source":233,"logo":53,"time":77},274474,"Johnson & Johnson's Bold Forecast: Navigating Challenges for a Promising Future","https://www.devdiscourse.com/article/business/3778026-johnson-johnsons-bold-forecast-navigating-challenges-for-a-promising-future",{"id":235,"title":236,"source":237,"logo":13,"time":77},275567,"Johnson & Johnson (JNJ) Reports Q4 Earnings: What Key Metrics Have to Say","https://www.nasdaq.com/articles/johnson-johnson-jnj-reports-q4-earnings-what-key-metrics-have-say",{"id":239,"title":240,"source":241,"logo":12,"time":77},274476,"Johnson & Johnson’s 2026 outlook beats forecasts despite expected pricing headwind","https://www.msn.com/en-us/money/companies/johnson-johnson-s-2026-outlook-beats-forecasts-despite-expected-pricing-headwind/ar-AA1UF3OT",{"id":243,"title":244,"source":245,"logo":16,"time":77},275568,"Johnson & Johnson (JNJ) Tops Q4 Earnings and Revenue Estimates","https://sg.finance.yahoo.com/news/johnson-johnson-jnj-tops-q4-212003520.html",{"id":247,"title":248,"source":249,"logo":10,"time":77},275565,"J&J Pins Oncology Sales Growth Prospects To Multiple Myeloma Strength","https://insights.citeline.com/scrip/scrip/business/earnings/jj-pins-oncology-sales-growth-prospects-to-multiple-myeloma-strength-Y7QBHQO7XBHMVIM3WLEMXHDE4M/",{"id":251,"title":252,"source":253,"logo":19,"time":77},276412,"Johnson & Johnson Beats Earnings and Lifts Outlook as Shares Drop","https://www.barrons.com/articles/johnson-johnson-earnings-beat-outlook-stock-falls-7b2c508e?gaa_at=eafs&gaa_n=AWEtsqdQhCmPyPJOgeheMTh_jTNcqd9pxfLNhxTNQJpjOAGfw4KlJAdSrIB1&gaa_ts=6971a586&gaa_sig=EbYeyYWN-PdYUYgqoRRDwp5kp2YQOfVCn1UERkCmfm84knprz1RFUe-8dtavnq54djzAOi50ya1OUm7_lhBP8w%3D%3D",{"id":255,"title":256,"source":257,"logo":5,"time":77},275566,"Johnson & Johnson (JNJ) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus","https://ca.investing.com/news/company-news/johnson--johnson-jnj-q4-2025-earnings-call-highlights-strong-revenue-growth-and--4412543",{"id":259,"title":186,"source":260,"logo":17,"time":77},274558,"https://www.marketwatch.com/story/j-j-expects-to-hit-100-billion-in-revenue-next-year-after-new-strategy-pays-off-e630fb43?gaa_at=eafs&gaa_n=AWEtsqcwWxHLI6KdsZ3W0C6L0QzIr7PL7MIlx6D1zUZF98TmJFagfFTCrLMK&gaa_ts=69713519&gaa_sig=975pFgHLW9JfEV0xakXCPCoe9xJG7IGjaHTillpL1kz5Th5_KukdTwAEHDhhOj7YKRCAKHSH29GiCVn3bxiN7w%3D%3D",{"id":262,"title":263,"source":264,"logo":29,"time":77},275569,"Johnson & Johnson Earnings: A Steady 2025 and Improving 2026","https://www.morningstar.com/stocks/johnson-johnson-earnings-steady-2025-improving-2026",{"id":266,"title":267,"source":268,"logo":23,"time":77},274559,"J&J’s cardiovascular business boosts medtech growth in 2025","https://www.medtechdive.com/news/jnj-q4-full-year-earnings-cardiovascular/810121/",{"id":270,"title":271,"source":272,"logo":5,"time":77},277580,"Johnson & Johnson (JNJ) Surpasses Q4 Revenue Expectations, Shares Dip","https://www.gurufocus.com/news/8535734/johnson-johnson-jnj-surpasses-q4-revenue-expectations-shares-dip?mobile=true",{"id":274,"title":275,"source":276,"logo":43,"time":77},277584,"Johnson & Johnson Q4 Earnings Call Highlights","https://www.marketbeat.com/instant-alerts/johnson-johnson-q4-earnings-call-highlights-2026-01-21/",{"id":278,"title":252,"source":279,"logo":19,"time":77},277583,"https://www.barrons.com/articles/johnson-johnson-earnings-beat-outlook-stock-falls-7b2c508e?gaa_at=eafs&gaa_n=AWEtsqctseLe23IiClKTnX9AFbyDEvHS419M_ilLUfcKTOIL93AnSYQytI63&gaa_ts=6971ddc7&gaa_sig=qaFW369rcpqC6QVvE4YGv-qWPHw4xxb-IgY0nDFFO7zf-FgR9fhouvABzlGhZsoyLyjlxAhBff4uxnM0b9RWOA%3D%3D",{"id":281,"title":282,"source":283,"logo":47,"time":77},274471,"Johnson & Johnson’s Profit And Sales Top Estimates","https://www.baystreet.ca/articles/techinsider.aspx?articleid=117910",{"id":285,"title":248,"source":286,"logo":10,"time":77},277582,"https://insights.citeline.com/scrip/business/earnings/jj-pins-oncology-sales-growth-prospects-to-multiple-myeloma-strength-Y7QBHQO7XBHMVIM3WLEMXHDE4M/",{"id":288,"title":120,"source":289,"logo":19,"time":77},274470,"https://www.barrons.com/articles/johnson-johnson-earnings-preview-what-to-expect-7b2c508e?gaa_at=eafs&gaa_n=AWEtsqe3aniFlTwI_550S8rkiuoD0JUxZa8xQ8KI7zU4CEjueMrH7GjPiDlq&gaa_ts=69713519&gaa_sig=bWE1lO8H6HO1AdN380pSHrdJDZBi8cV-lbXHgTrx9qLKWeavkOCmvJkh8ztVLTYyJKzi-pR5J2wEJwICSsVXjg%3D%3D",{"id":291,"title":80,"source":292,"logo":11,"time":77},277581,"https://www.wsj.com/business/earnings/johnson-johnson-jnj-q4-earnings-report-2025-f2a1b48f?gaa_at=eafs&gaa_n=AWEtsqeOKjH4JWgNH_uuKbkFFg4HmgT9UK8WtqpBEk_UMteE6VAGl_QBlzzP&gaa_ts=6971ddc7&gaa_sig=0QoXTAsLDzz9vshmiwArxAs51Qaq42oiza-P3XoeaV2hBzuWiHvxLrgkKG2Rn1mSFIW1QVZze4tCwYCA_WN8Sw%3D%3D",{"id":294,"title":295,"source":296,"logo":27,"time":77},274462,"Led by Darzalex surge, J&J expects revenue to reach $100B in 2026","https://www.fiercepharma.com/pharma/led-darzalex-surge-jj-expects-revenue-reach-100b-2026",{"id":298,"title":228,"source":299,"logo":5,"time":77},277577,"https://pharma.economictimes.indiatimes.com/news/financial-performance/jj-sees-2026-profit-above-wall-street-estimates-despite-tariffs-hit-trump-pricing-deal/127083787",{"id":301,"title":302,"source":303,"logo":15,"time":77},274461,"Johnson & Johnson Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Johnson & Johnson (NYSE:JNJ)","https://www.benzinga.com/analyst-stock-ratings/price-target/26/01/50026741/johnson-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts-4",{"id":305,"title":306,"source":307,"logo":44,"time":308},277576,"Johnson & Johnson Crushes Patent, Pricing Probs","https://www.thedailyupside.com/industries/healthcare/johnson-johnson-overcomes-patent-and-pricing-probs/","3天前",{"id":310,"title":311,"source":312,"logo":22,"time":77},274464,"J&J brushes off MFN impact, predicts strong growth for 2026","https://endpoints.news/johnson-johnson-brushes-off-mfn-impact-sees-strong-growth-for-2026/",{"id":314,"title":315,"source":316,"logo":5,"time":308},277575,"Johnson & Johnson Reports Q4 and Full-Year 2025 Sales Growth, Issues 2026 Guidance","https://www.visionmonday.com/eyecare/article/johnson-and-johnson-reports-q4-and-full-year-2025-sales-growth-issues-2026-guidance/",{"id":318,"title":319,"source":320,"logo":50,"time":77},274463,"J&J Sees Strong 2026 Growth Despite Deal to Cut Prices","https://www.bloomberg.com/news/articles/2026-01-21/j-j-sees-strong-2026-performance-despite-deal-to-cut-prices",{"id":322,"title":323,"source":324,"logo":23,"time":77},274466,"J&J eyes $100B in sales amid gains for cancer, immune drugs","https://www.biopharmadive.com/news/johnson-johnson-2025-earnings-sales-cancer-immune-drugs/810097/",{"id":326,"title":327,"source":328,"logo":54,"time":77},276403,"Vital Signs: Unwrapping J&J's $100 billion ambition","https://firstwordpharma.com/story/7076696",{"id":330,"title":331,"source":332,"logo":25,"time":77},274465,"J&J Aims for $100B in Sales, Puts Stelara Patent Cliff ‘in the Rearview Mirror’","https://www.biospace.com/business/j-j-aims-for-100b-in-sales-puts-stelara-patent-cliff-in-the-rearview-mirror",{"id":334,"title":335,"source":336,"logo":24,"time":77},276404,"Johnson & Johnson Projects Strong Growth Beyond STELARA","https://www.tipranks.com/news/company-announcements/johnson-johnson-projects-strong-growth-beyond-stelara",{"id":338,"title":186,"source":339,"logo":17,"time":77},276525,"https://www.marketwatch.com/story/j-j-expects-to-hit-100-billion-in-revenue-next-year-after-new-strategy-pays-off-e630fb43?gaa_at=eafs&gaa_n=AWEtsqcI5oXw9xL-wY-eky57-SfqeMkiZ15vEt_p7cku-Jvy1-PvfX789jkW&gaa_ts=6971a586&gaa_sig=eMAP9WqKO6nTTuJdQwJf3XSBGP5y5_Hiv8SDsGGrShp-DuYTW2ws7f5mkK1QbpogsmEVs1gxH0XsHJzM25ARyQ%3D%3D",{"id":341,"title":342,"source":343,"logo":14,"time":77},274468,"J&J sees 2026 profit above Wall Street estimates despite tariffs hit, Trump pricing deal By Reuters","https://www.investing.com/news/stock-market-news/johnson--johnson-forecasts-2026-profit-above-wall-street-estimates-4457206",{"id":345,"title":346,"source":347,"logo":5,"time":77},277579,"Johnson & Johnson (JNJ) Surpasses Revenue Expectations","https://www.gurufocus.com/news/8535814/johnson-johnson-jnj-surpasses-revenue-expectations?mobile=true",{"id":349,"title":350,"source":351,"logo":45,"time":77},274467,"Dow Jones Top Company Headlines at 11 AM ET: J&J's Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales | Nvidia ...","https://news.futunn.com/en/post/67711092/dow-jones-top-company-headlines-at-11-am-et-j",{"id":353,"title":143,"source":354,"logo":5,"time":77},277578,"https://www.gurufocus.com/news/8540792/johnson-johnson-jnj-reports-strong-growth-and-strategic-investments-in-2025?mobile=true",{"id":356,"title":357,"source":358,"logo":5,"time":77},276407,"Johnson & Johnson Q4 2025 slides: Revenue accelerates as company targets $100B milestone","https://au.investing.com/news/company-news/johnson--johnson-q4-2025-slides-revenue-accelerates-as-company-targets-100b-milestone-93CH-4216307",{"id":360,"title":361,"source":362,"logo":5,"time":77},274469,"Johnson & Johnson MedTech sales up 7.5% in Q4","https://www.massdevice.com/johnson-johnson-medtech-sales-up-7-5-in-q4/",{"id":364,"title":236,"source":365,"logo":5,"time":77},276408,"https://finance.yahoo.com/news/johnson-johnson-jnj-reports-q4-213003837.html",{"id":367,"title":368,"source":369,"logo":49,"time":77},276405,"J&J sales up 9.1% to USD 24.6B in Q4 2025","https://medicalbuyer.co.in/jj-sales-up-9-1-to-usd-24-6b-in-q4-2025/",{"id":371,"title":80,"source":372,"logo":11,"time":77},276406,"https://www.wsj.com/business/earnings/johnson-johnson-jnj-q4-earnings-report-2025-f2a1b48f?gaa_at=eafs&gaa_n=AWEtsqfB9vXr7tZfJ8wbi2E39PI6CYRxMf7pTYjHnFU89oZuXjFTPZTMXpFm&gaa_ts=6971a586&gaa_sig=q-5bgUWhmz1DG7ebZnuPaXLlOULLafqwza2evuuubQPOwRF1cqyBy_jjd-OTIhfAB0sPf-RZGE51mAP9pvP0aw%3D%3D",{"id":374,"title":244,"source":375,"logo":5,"time":77},276409,"https://finance.yahoo.com/news/johnson-johnson-jnj-tops-q4-212003520.html","#4774ddff","#4774dd4d",1769421014356]